By Plenary Sessions: Irja Lutsar

The criticism is aimed at the market situation of pharmaceutical wholesalers (low competition, predominantly two players) and the Ministry of Social Affairs (SOM), which failed to convince the commission of the necessity of broad import rights. Concern is expressed that the state is interfering excessively in the private sector-driven pharmaceutical market and that there is a lack of open dialogue on this issue. It favors narrower regulation that would restrict hospital activities to emergency situations.

There were no opposing viewpoints or criticism aimed at political opponents. The discussion focused instead on constructive debate and responding to questions raised by committee members, all aimed at improving and clarifying the draft bill.

The criticism is aimed primarily at the bill's deficiencies concerning data protection, rather than targeting specific opponents or political groups. There is no intense attack or personal criticism involved; instead, it is simply the raising of a procedural issue.